Somatostatin analogs for pancreatic neuroendocrine tumors: is there any benefit when Ki-67 Is >= 10%?
Authors
Merola, EGordoa, TA
Zhang, P
Al-Toubah, T
Pelle, E
Liu, M
Laskaratos, F
de Mestier, L
Lamarca, Angela
Hernando, J
Cives, M
van Leeuwaarde, R
Affiliation
Azienda Provinciale per i Servizi Sanitari (APSS), Trento, ItalyIssue Date
2020